Cidara Therapeutics Inc (CDTX): Raymond James has a Target of $20 for C...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	46
Posts	10977
Boards Moderated	0
Alias Born	02/14/2007

now invest

Re: None

Wednesday, 05/23/2018 10:32:43 AM

Wednesday, May 23, 2018 10:32:43 AM

Raymond James has a Target of $20 for CDTX.. High risk... STRONG BUY !! Boy... I would love to see just $10 this year !!

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CDTX News

Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 09:22:11 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/23/2024 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 01:00:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 12:33:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 06:22:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:08:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:05:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 02:36:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 05:24:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:24:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 08:22:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:05:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 11:40:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:03:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 08:01:05 PM
Biotech Rallies Right Before Opening Bell • AllPennyStocks.com • 08/01/2023 02:30:00 PM

More CDTX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover